V
VolitionRx Limited (VNRX)
ASE – Real Time Price. Currency in USD
2.17
-0.15 (-6.47%)
Market open: May 13, 2026, 10:00 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
2.17
-0.15 (-6.47%)
Market open: May 13, 2026, 10:00 AM EDT
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
| Name | Position |
|---|---|
| Dr. Gaetan Michel Ph.D. | Chief Operating Officer |
| Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer |
| Dr. Jasmine Kway Ph.D. | Chief Executive Officer of Singapore Volition |
| Mr. Cameron Reynolds MBA | Founder, CEO, President & Director |
| Mr. Gael Forterre M.B.A. | Chief Commercial Officer |
| Mr. Nicholas Plummer | Group General Counsel |
| Mr. Rodney Gerard Rootsaert LLB | Corporate Secretary |
| Mr. Terig Hughes | CFO & Treasurer |
| Ms. Louise Batchelor Day | Group Chief Marketing & Communications Officer |
| Ms. Sharon Ballesteros | U.S. Head of Quality & Development Process |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | 10-K/A | vnrx_10k.htm |
| 2026-04-28 | 8-K | vnrx_8k.htm |
| 2026-04-23 | 8-K | vnrx_8k.htm |
| 2026-04-17 | 8-K | vnrx_8k.htm |
| 2026-04-01 | 8-K | vnrx_8k.htm |
| 2026-03-31 | 8-K | vnrx_8k.htm |
| 2026-03-31 | 10-K | vnrx_10k.htm |
| 2026-02-20 | 8-K | vnrx_8k.htm |
| 2026-02-17 | CORRESP | filename1.htm |
| 2026-02-11 | DEF 14A | vnrx_def14a.htm |